VEGFR3gene structure, regulatory region, and sequence polymorphisms
- 1 April 2001
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 15 (6) , 1028-1036
- https://doi.org/10.1096/fj.00-0383com
Abstract
Vascular endothelial growth factor receptor 3 (VEGFR-3) is required for cardiovascular development during embryogenesis. In adults, this receptor is expressed in lymphatic endothelial cells, and mutant VEGFR3 alleles have been implicated in human hereditary lymphedema. To better understand the basis of its specific endothelial lineage-restricted expression, we have characterized the VEGFR3 gene and its regulatory 5′ flanking region. The human gene contains 31 exons, of which exons 30a and 30b are alternatively spliced. The VEGFR3 proximal promoter is TATA-less and contains stretches of sequences homologous with the mouse Vegfr3 promoter region. In transfection experiments of cultured cells, the Vegfr3 promoter was shown to control endothelial cell-specific transcription of downstream reporter genes. This result was further confirmed in vivo; in a subset of transgenic mouse embryos, a 1.6 kb Vegfr3 promoter fragment directed weak lymphatic endothelial expression of the LacZ marker gene. This suggests that endothelial cell-specific elements occur in the proximal promoter, although further enhancer elements are probably located elsewhere. The sequence, organization, and variation in the VEGFR3 gene and its regulatory region provide important tools for the molecular genetic analysis of the lymphatic system and its disorders.—Iljin, K., Karkkainen, M. J., Lawrence, E. C., Kimak, M. A., Uutela, M., Taipale, J., Pajusola, K., Alhonen, L., Halmekytö, M., Finegold, D. N., Ferrell, R. E., Alitalo, K. VEGFR3 gene structure, regulatory region, and sequence polymorphisms.Keywords
This publication has 45 references indexed in Scilit:
- Congenital Hereditary Lymphedema Caused by a Mutation That Inactivates VEGFR3 Tyrosine KinaseAmerican Journal of Human Genetics, 2000
- Cardiovascular gene therapyThe Lancet, 2000
- The Human ICAM-2 Promoter is Endothelial Cell-specific in Vitro and in Vivo and Contains Critical Sp1 and GATA Binding SitesJournal of Biological Chemistry, 1998
- TARGETING GENE EXPRESSION TO ENDOTHELIAL CELLS IN TRANSGENIC MICE USING THE HUMAN INTERCELLULAR ADHESION MOLECULE 2 PROMOTER1Transplantation, 1996
- Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endotheliumNature, 1995
- Failure of blood-island formation and vasculogenesis in Flk-1-deficient miceNature, 1995
- FLT4 Receptor Tyrosine Kinase Gene Mapping to Chromosome Band 5q35 in Relation to the t(2;5), t(5;6), and t(3;5) TranslocationsGenes, Chromosomes and Cancer, 1993
- Chromosomal localization of FLT4, a novel receptor-type tyrosine kinase geneGenomics, 1992
- Mechanism of transcriptional activation by Sp1: Evidence for coactivatorsCell, 1990
- On the origin of the abdominal lymphatics in mammals from the vena cava and the renal veinsThe Anatomical Record, 1912